Insider Trading History of Lucera Erick

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Lucera Erick since 2017. This trader's CIK number is 1697616. At the time of last reporting, Lucera Erick was the EVP, CHIEF FINANCIAL OFFICER of Editas Medicine, Inc.. (stock ticker symbol EDIT). Also see all insider trading activities at Editas Medicine, Inc..

Note that in the past Lucera Erick also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Valeritas Holdings Inc. (VLRX) by Lucera Erick

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 VLRX 4,500 $37,425 0 $0 0 $0

Yearly summary of insider trading at Editas Medicine, Inc. (EDIT) by Lucera Erick

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 EDIT 0 $0 4,109 $7,030 0 $0
2024 EDIT 0 $0 22,337 $125,399 0 $0

Yearly summary of insider trading at Beyond Air, Inc. (XAIR) by Lucera Erick

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 XAIR 39,266 $15,549 0 $0 0 $0
2023 XAIR 2,000 $13,634 0 $0 0 $0
2021 XAIR 0 $0 0 $0 1,171 $4,976
2018 XAIR 0 $0 0 $0 1,171 $4,976


Insider trading activities at 3 companies by Lucera Erick:

1. Valeritas Holdings Inc. (VLRX)

2. Editas Medicine, Inc. (EDIT)

3. Beyond Air, Inc. (XAIR)

Table 1. Insider trading of Valeritas Holdings Inc. (VLRX) by Lucera Erick

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-05-22 VLRX Buy 1,500 4.95 7,425
2017-03-23 VLRX Buy 3,000 10.00 30,000

Table 2. Insider trading of Editas Medicine, Inc. (EDIT) by Lucera Erick

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-04 EDIT Sale 4,109 1.71 7,030
2024-05-20 EDIT Sale 22,337 5.61 125,399

Table 3. Insider trading of Beyond Air, Inc. (XAIR) by Lucera Erick

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-08-14 XAIR Buy 39,266 .40 15,549
2023-03-16 XAIR Buy 2,000 6.82 13,634
2021-02-16 XAIR Option Ex 1,171 4.25 4,976
2018-02-16 AITB Option Ex 1,171 4.25 4,976

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lucera Erick (EVP, CHIEF FINANCIAL OFFICER of Editas Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.